Global Pediatric Health · 2016 · 21 citations · 31 references
MedicineInfectious DiseasesPediatricsPediatric Infectious DiseasesPediatric PharmacotherapyPediatric PulmonologyFever ManagementPediatric Clinical TrialsAcute Upper Respiratory Tract InfectionsAdd-on TherapyComparative Clinical EffectivenessDisease Severity IndexFever In ChildrenRespiratory Infections In ChildrenSymptomatic PharmacotherapyUpper Respiratory Infections
We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same ST plus a homeopathic medication (Influcid; IFC-group) for 7 days. Outcome assessment was based on symptom and fever resolution and the Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21). A total of 261 pediatric (<12 years) patients (130 IFC-group; 131 ST-group) were recruited in Germany and the Ukraine. The IFC-group used less symptomatic medication, symptoms resolved significantly earlier (P = .0001), had higher proportions of fever-free children from day 3 onwards, and the WURSS-assessed global disease severity was significantly less (P < .0001) during the entire URTI episode. One adverse event (vomiting) was possibly related to IFC. IFC as add-on treatment in pediatric URTI reduced global disease severity, shortened symptom resolution, and was safe in use.
31
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations
Trends in Antimicrobial Prescribing Rates for Children and Adolescents
Linda F. McCaig · JAMA · 2002 · 527 citations
Henrik Hasman, Anette M. Hammerum, Frank Hansen et al. · Eurosurveillance · 2015 · 410 citations · Full text